In the future, new “smart” drugs to fight cancer could have a natural origin and, thanks to the knowledge of their action mechanism, present reduced adverse effects by exerting anti-cancer activities via epigenetic modulation on responsive cells, such as HDAC inhibition. Here, HDAC9 is linked to cancer.